Clinical trial
Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis
NCT02473406 is registered in ClinicalTrials.gov with Weiqin Li as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis
- Lead sponsor
- Weiqin Li
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 27, 2018
- Completion date
- March 24, 2021
- Enrollment
- 508 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.